Scolamiero John C MD - Fairfield, New Jersey 07004

Scolamiero John C MD is categorized under Doctors in Fairfield, NJ .

Business Name: Scolamiero John C MD
Contact Person: John Scolamiero
Address: 150 Fairfield Road, Fairfield, New Jersey 07004
Phone Number: (973) 227-0020
Annual Revenue (USD): $500.000 to $999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Liotti Joseph B DO - Fairfield, NJ 07004
Scollo Paul R DPM - Fairfield, NJ 07004
Kuruvilla Ruben MD - Fairfield, NJ 07004
Livshits Larisa L MD - Fairfield, NJ 07004
DE Corso Joseph A MD - Fairfield, NJ 07004
Bhatt Rupal S MD - Fairfield, NJ 07004
Derham Elizabeth N MD - Fairfield, NJ 07004
Greene Norman X MD - Fairfield, NJ 07004
Bhatt Shirish V MD - Fairfield, NJ 07004
Fairfield Medical Group - Fairfield, NJ 07004
Cardiology Associates - Fairfield, NJ 07004
Elaine D Garrod Psy - Fairfield, NJ 07004
Tri-County Neurology & Rehab - Fairfield, NJ 07004
A R Pugliese Md - Fairfield, NJ 07004
Raj Sharma Kumar Md - Fairfield, NJ 07004
Lacara Dena L DO - Fairfield, NJ 07004
Ciolino Robert B MD - Fairfield, NJ 07004
Liotti Linda R DO - Fairfield, NJ 07004
Shajenko Lydia MD - Fairfield, NJ 07004

The company Scolamiero John C MD provides B2C services in the form of Doctors from its single location in New Jersey. 1 to 4 employees work for Scolamiero John C MD, and the business now earns $500.000 to $999.999 per annum.

Scolamiero John C MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Scolamiero John C MD, please call John Scolamiero with the phone number (973) 227-0020 or visit its single location at 150 Fairfield Road in Fairfield, New Jersey 07004.

The location of the single location can also be found using the coordinates 40.8757,-74.29658. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.